ACCOMPLISH

Serial Number 88778614
606

Registration Progress

Application Filed
Jan 30, 2020
Under Examination
Jul 28, 2020
Approved for Publication
Jun 2, 2020
Published for Opposition
Jun 2, 2020
Registered

Trademark Image

ACCOMPLISH

Basic Information

Serial Number
88778614
Filing Date
January 30, 2020
Published for Opposition
June 2, 2020
Abandonment Date
August 28, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 28, 2023
Classes
042

Rights Holder

Cingulate Therapeutics LLC

16
Address
1901 W 47th Place, Suite 310
Kansas City, KS 66205

Ownership History

Cingulate Therapeutics LLC

Original Applicant
16
Kansas City, KS

Cingulate Therapeutics LLC

Owner at Publication
16
Kansas City, KS

Legal Representation

Attorney
Susan Neuberger Weller

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

40 events
Date Code Type Description Documents
Aug 28, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 28, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 9, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 9, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 24, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 24, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 17, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 15, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 15, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 15, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 25, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 21, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 21, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 21, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 28, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 26, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 26, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 26, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 20, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 20, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 20, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 26, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 22, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 22, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 22, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 28, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 2, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 2, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 13, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 28, 2020 ALIE A ASSIGNED TO LIE Loading...
Apr 21, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 21, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 21, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 21, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 21, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 20, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 4, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 3, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention deficit hyperactivity disorder (ADHD)

Classification

International Classes
042